An experimental treatment appears to postpone Alzheimer’s symptoms in some people genetically destined to get the disease at a young age. Researchers reported Wednesday that people who had a sticky gunk named amyloid removed from their brains for an average of eight years saw their risk of developing Alzheimer’s symptoms cut in half — at least for now. Washington University in St. Louis is continuing the study in hopes of finding proof. Participating families worry that needed funding is caught in delays at the National Institutes of Health. An experimental treatment appears to postpone Alzheimer’s symptoms in some people genetically destined to get the disease at a young age. Researchers reported Wednesday that people who had a sticky gunk named amyloid removed from their brains for an average of eight years saw their risk of developing Alzheimer’s symptoms cut in half — at least for now. Washington University in St. Louis is continuing the study in hopes of finding proof. Participating families worry that needed funding is caught in delays at the National Institutes of Health. AP Technology and Science
Headlines